Skip to main content
padlock icon - secure page this page is secure

Open Access Ganoderma lucidum (Ling-zhi): The Impact of Chemistry on Biological Activity in Cancer

Download Article:
(PDF 312.3 kb)
Background: Ganoderma (Ganodermataceae), a genus of medicinal mushrooms, has been employed as an herbal medicine in Traditional Chinese medicine (TCM) for over 2000 years. The fruiting bodies have been used historically in TCM, while the mycelia, and spores are now also used as a tonic, to stimulate the immune system and treat many diseases, including cancers.

Objective: To review the anti-cancer research on G. lucidum (GL) from 2005 up to May 2016 and correlate these data with analysis of the active chemical constituents.

Methods: Literature searches were performed from 2005 to May 2016 in various databases such as Pub- Med, SciFinder, Napralert, and Google Scholar for peer-reviewed research literature pertaining to Ganoderma lucidum and cancer.

Results: Of the >200 known Ganoderma species, only two species, G. lucidum (W. Curtis: Fr.) P. Karst and G. sinense Zhao, Xu et Zhang, are officially recognized as “Ling-zhi” in the Chinese Pharmacopoeia. Both species are thought to have similar biological effects. “Ling-zhi” is purported to have anticancer effects, and is also used in the promotion of health and longevity. Numerous polysaccharides and triterpenes have been identified in G. lucidum and have anticancer effects in both cell culture and animal models.

Conclusion: The current published literature suggests that G. lucidum extracts have excellent potential for use in cancer therapy, as both the triterpenes and polysaccharides appear to have anti-cancer effects both in vitro and in vivo. However, many problems still exist including significant quality issues including taxonomy and identification of species, parts used, and the production of extracts with active constituents.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Ganoderma lucidum; Ganodermataceae; Ling-zhi; cancer; polysaccharides; triterpenes

Document Type: Research Article

Publication date: March 1, 2017

More about this publication?
  • The journal aims to provide updates to researchers about new bioactive compounds with proven activities in various biological screenings and pharmacological models. The journal will contain information about the structures, biological activities and sources of chemical entities discovered or designed by researchers and published in leading journals. The aim is to provide a valuable information source of bioactive compounds synthesized or isolated, which can be used for further development of pharmaceuticals by industry and academia.

    The journal should prove to be essential reading for pharmacologists, pharmaceutical chemists and medicinal chemists who wish to be kept informed and up-to-date with the latest and most important developments about new bioactive compounds of natural or synthetic origin, including recent patents.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more